Introduction
Glucocorticoids hormones easily cross cell membranes due to their lipophilicity and exert physiological effects in almost every tissue of the human body (Cockrem 2013 , Walker, et al. 2012 . Synthetic or semi-synthetic glucocorticoids (GCs) aim to optimize the immunosuppressive, angiostatic and anti-inflammatory properties of cortisol, whilst reducing their mineralocorticoid side effects. GCs remain the first-line therapy in number of inflammatory conditions and are administered locally or systemically (Barnes 2005 , Logie, et al. 2010 . Recognized side effects of GCs include microvascular fragility, atrophy as well as reduced microvascular density in skin, bone and muscle (Anacker, et al. 2011 , Schacke, et al. 2002 , Torriglia, et al. 2010 . Folkman et al. demonstrated that Hydrocortisone (Hydro) and Dexamethasone (Dexa), at µg/µl concentrations, prevent heparin-stimulated angiogenesis in the chick chorioallantoic membrane and induce the regression of capillaries within the surrounding tissue Ingber 1987, Folkman, et al. 1983) . Later, Small et al. showed that corticosterone (300-600nM) inhibits angiogenesis in vitro and in vivo. In addition, inhibition of 11beta-hydroxysteroid dehydrogenase type 1 favors corticosterone production and enhances angiogenesis providing evidence for the angiostatic role of endogenous corticosteroids (Small, et al. 2005) . More recently, the mechanisms of the angiostatic effects of physiological doses of the endogenous corticosterone have been studied in more details, revealing a receptormediated effect on Vascular Endothelial Growth Factor production, activation of Matrix Metallo peptidase 2 and the inhibition of endothelial cells tube-like structure formation (Shikatani, et al. 2012) . Systemic administration of GCs triggered cell death of macrophages (Schmidt et al., 1999) , human epithelial cells of the lens (Sharma, et al. 2011) , pericytes (Katychev, et al. 2003) and induced necrosis of microvessels and osteocytes in the co-femoral articulation and bruises (Allen, et al. 2003 , Hu, et al. 2006 ).
The possibility that higher doses of corticosteroids may exert further direct effects on an established microvasculature has not been extensively explored.
In ophthalmology, GCs are commonly used not only for the treatment of ocular inflammation but also to manage macular edema of inflammatory and non-inflammatory origins such as diabetic retinopathy or retinal vein occlusion. As chronic use is required, high doses of the hydrophobic Triamcinolone Acetonide (TA) or polymeric implants releasing Dexa for sustained periods are used in order to reduce the frequency of intraocular administrations (Behar-Cohen 2011) . In addition, ocular tissues are resistant to the use of GCs due to the high concentration of natural steroid (Knisely, et al. 1994) , explaining the high concentrations (about 1mg/ml) used clinically. GCs exert rapid and striking effects on retinal edema (Miyamoto, et al. 2006) but are associated with potential side effects on the posterior segment of the eye including a reduction of the choroidal vascular network, a decreased retinal vessels diameter in rats and a decrease in the retinal vascular density in the developing retinal vasculature (Hartnett, et al. 2006 , Valamanesh, et al. 2009 ). Whether GCs can directly affect endothelial cell viability has not been fully explored.
On the one hand, as compared to bone, muscle or skin where vasculature is constantly remodeled, retinal endothelial cells proliferate at a very slow rate in normal conditions (Joussen, et al. 2007 ). On the other hand, GCs failed to demonstrate anti-angiogenic effects in retinal or choroidal neovascularisation (Chan, et al. 2011 , Geltzer, et al. 2013 ) suggesting that GCs may exert different effects on endothelial cells from different tissue origin. We have previously shown that clinical doses of intraocular TA induced a caspase independent apoptosis associated with the absence of TUNEL labeling on bovine retinal endothelial cells in culture and in retinal neovessels (Torriglia, et al. 2010 , Valamanesh, et al. 2009 ). This suggested that non classical mechanism of cell death like autophagy, caspase independent apoptosis or necrosis (Galluzzi, et al. 2012) could be involved in this toxicity.
Taken together, all these results suggest that the molecular mechanisms underlying GCs effects on the vasculature are complex and involve different cellular and molecular pathways depending on the endothelial cell type, the GC concentration and duration of exposure.
The aim of this study was to compare the potential toxicity of commonly used GCs (Le Jeunne 2012) on vascular endothelial cells of different origin and to investigate the underlying mechanisms of toxicity for the different GCs. This is a very important point since the evaluation of toxicity relays frequently in caspase-dependent markers and could be underestimated if other molecular mechanisms are involved. The relevance of our in vitro findings was assessed by analyzing GCs effects on rat retinal explants.
MATERIALS AND METHODS

Animals
Adult males Lewis rats (6-8 weeks old, Janvier, Le Genest-Saint-Isle, France) were used for the ex-vivo experiments. Rats were sacrificed by carbon dioxide inhalation. All experiments were performed in accordance with the European Communities Council Directive 86/609/EEC and approved by the local ethical committee of University Paris Descartes.
HMEC Culture
All culture media and additives were purchased from Invitrogen (Cergy Pontoise, France). All glucocorticoids (GCs) were purchased from Sigma-Aldrich (Saint-Quentin Fallavier France).
Human dermal microvascular endothelial cells (HMEC) is a transformed cell line which has been transfected with a PBR-322 plasmid containing a region encoding for the SV40 (Simian Virus) gene (Ades, et al. 1992) . Cultures were maintained at 37°C in a humidified atmosphere containing 5% CO 2 . They were cultured in the Endothelial Basal Medium supplemented with L-Glutamine and Hepes 15 mM, 10 % complement-free Fetal Calf serum (DFCS) and 1% streptomycin (100 µg/ml) -penicillin (100 units/ml). Confluent HMEC cells were treated with the LC 50 of GCs: 275 µM Hydrocortisone (Hydro), 255 µM Dexamethasone (Dexa), 230 µM Triamcinolone Acetonide (TA) and 2 mM Dexamethasone-Phosphate (Dexa-Ph) in media supplemented with 2% of DFCS for 24 h. Although cell survival reaches a plateau with DexaPh, 2 mM was the concentration giving the most reproducible results. The hydrophobic GCs (all except for Dexa-Ph) were previously dissolved in ethanol 100% then in the medium (ethanol final concentration 1%). This step was introduced in order to have a known concentration of the GCs in the media of treatment. Actually, hydrophobic GCs as TA, for instance, precipitate in aqueous medium. This false the real concentration of the GC and generates crystals that precipitate, stick to cells and cause a mechanical damage.
BREC Culture
Bovine Retinal Endothelial cells (BRECs) were isolated from the Bovine retinal microcirculation as previously reported (Capetandes and Gerritsen 1990) . BREC were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with GlutaMAX, 4.5 g /L Glucose, 10% decomplemented fetal calf serum (DFCS), 1% streptomycin (100 µg/ml) -(100 Unites/ml) penicillin, 0.5% Fungizone-Amphotericine and 20 ng/ml FGFb. Cultures were maintained at 37°C in a humidified atmosphere containing 5% CO 2 . Confluent BRECs cells were treated with LC 50 GCs 1.37 mM for Hydro, 765 µM Dexa, 460 µM TA and 2 mM for Dexa-Ph in media supplemented with 2% DFCS for 24 h. The hydrophobic GCs (all except for Dexa-Ph) were previously dissolved in ethanol 100% then in the medium (ethanol final concentration 1%). The choice of this cell line was forced by the difficulty of obtaining an equivalent from human origin.
Rat Retinal Explants
After enucleation, rat retinas were isolated immediately under aseptic conditions. They were flattened by 4 orthogonal incisions, then transferred onto a Cyclopore 0.2 µm polycarbonate membrane (Whatman, Maidstone, England), and mounted with the vitreal side up. The support membranes were placed in 6-well tissue culture plates containing 2 ml DMEM supplemented with 10% steroid-free FCS, 1% penicillin-streptomycin and 0.1% Amphotericin-B. Explants were treated with LC 50 of BREC cells as described for BREC cultured cells.
MTT ASSAY
The MTT assay is a colorimetric test that was developed to determine the survival and growth of eucaryotic cells in proliferation or to evaluate cytotoxicity (Mosmann 1983 
Internucleosomal DNA degradation
Internucleosomal DNA degradation assay was performed as already described by Zhua et al (Ning Zhua 1997) . Briefly, cells from each condition were obtained by scraping in culture medium. A cell pellet was obtained by centrifugation at 173g, then the pellet was extracted in 30µl of Sarkozyl (50 mM of Tris,10 mM of EDTA, 2% of N-Lauryl sarcosine at pH 7.5) and immediately stored on ice. The cellular lysates were then treated for 2 h with1µl of proteinase K 20 mg/ml at 45°C and 1µl of RNase-A 10 mg/ml for 1hr at 37°C. Finally, the DNA samples were run in a Tris-Acetate-EDTA 2% agarose gel and visualized by staining with ethidium bromide.
Lactate dehydrogenase (LDH) assay
LDH is a cytoplasmic enzyme not released during active cell death like apoptosis, paraptosis, LEI/L-DNase II cell labeling was performed as described before (Altairac, et al. 2003) . For cleaved Caspase-3 labeling, after fixation and permeabilization performed as above, cells
were washed three times with PBS and then saturated with 1% skim milk in PBS for 1 hr.
Cells were then incubated with monoclonal antibody against active caspase-3 (Cell Signaling, 9661S) diluted 1:100 in 0.1% skim milk PBS, overnight at 4°C, washed five times for 5 min with PBS, incubated with the secondary antibody (Invitrogen, A10040, Alexa Fluor® antirabbit) diluted 1:200 in PBS, for 1 h at room temperature in a humidified chamber. Cells were then washed three times with PBS in the dark and finally mounted with Fluoromount (Sigma Life Sciences). Cells were observed using a fluorescence microscope Olympus BX51, equipped with 40x and 60x objectives. Confocal analysis was done using a Zeiss LMS710 microscope. Adobe Photoshop was used as elaborating software.
Cytoplasm and nucleus fractions
Cells were collected by trypsinization and rinsed twice in PBS, then, 2.10 6 cells were resumed in 500 µl of a hypotonic solution of MgCI 2 (1.5 mM) during 10 min. Cells were then crushed with a Dounce potter and centrifuged 10 min at 390 g. The cytoplasmic fraction contained in the supernatant was removed and the nuclear fraction was resuspended in 1 mL of MgCI 2 (1.5 mM) and centrifuged during 10 min at 390 g twice, then resuspended in 200 µl of 10 mM Tris, 60 mM NaCl, 200 mM sucrose pH 7,4. 
Western blot analysis
Cells were disrupted in RIPA buffer (50 mM Tris, 150 mM NaCl, 1% Triton-X100, 1%
Sodium Deoxycholate, 1% Sodium Dodecyl Sulfate) or M-PER buffer (Thermo Scientific, 78503) in the presence of protease and phosphatase inhibitors. The protein concentration was determined by the BCA method (as previously described). The proteins were distorted in Laemmli (62 mM Tris-HCI 6.8 pH, 2% SDS, 10% glycerol, 5% ß-mercaptomethanol, 0.01% Bromophenol blue). Equal amounts of protein (20 µg) were separated on a 12% Tris-Glycine gel. Nitrocellulose membrane transfer was performed at 100 V for 1:30 h at 4°C and monitored by the membrane staining with Ponceau Red (Sigma-Aldrich). The membrane was saturated with 5% skim milk in PBS for 1 h at room temperature then incubated overnight at 4°C with the primary antibodies against caspase-3 (1:1000) (Santa Cruz,1224), cleaved caspase-3 (1:1000) (Cell Signaling,9661), AIF (1:1000) (Santa Cruz, 9416), LEI/L-DNaseII
(1:1000) (Torriglia, et al. 1995) , β-Actin (1:1000) (Santa Cruz, 1616), Lamin B (1:1000) (Santa Cruz, 6216), LC3-II (1:1000) (Santa Cruz sc-16756). After 5 washes in PBS containing 0.1% Tween-20, the membrane was incubated for 1 hr with the anti-rabbit (Victor Laboratories, PI-1000) or anti-Goat (Victor Laboratories, PI-9500) secondary antibodies conjugated to peroxidase, diluted 1:5000, in PBS containing 0.5% Skim Milk and then washed 5 times in PBS. PARP (Poly ADP-Ribose Polymerase) western blot was performed as already described by Blenn and al (Blenn, et al. 2006 
Retinal flat mounting
After GCs treatment, retinas were immediately washed and fixed with 4% paraformaldehyde for 15 min. They were then permeabilized with PBS containing 0.1% Triton X-100, and 
Statistics
Data were expressed as means ± SE. Statistical analysis was made using the Graphpad Prism5
program (Graphpad Software, San Diego, CA, USA). Mann-Whitney test comparison was used. P < 0.05 deemed significant, unless otherwise stated. 
The mechanisms of cell death induced by GCs:
In order to analyze the mechanisms underlying GC toxicity on endothelial cells, we successively evaluated markers for autophagy, necrosis, caspase-dependent and caspaseindependent apoptosis. These analyses were performed on HMEC using for each steroid its LC 50 as determined above in order to have results obtained with the same degree of toxicity.
Autophagy
The presence of autophagy was analyzed using an antibody against MAP-LC3 (microtubuleassociated protein 1 light chain 3). This protein is integrated to the autophagosomes membranes (Tanida, et al. 2004) . In physiological conditions, the quiescent LC3 has a diffuse distribution in the cytoplasm. Once the autophagy activated, LC3 concentrates in the autophagosome membrane and gives a punctuate labeling as observed in cells cultured in a depleted amino-acid (AA) medium, used as a positive control (Fig 2A) . No such labeling was observed with GCs treatment eliminating autophagy as a potential mechanism of cell death (Fig 2A) . This result was confirmed by western blot. As seen in Fig 2B only in AA depleted medium the lipidated form of LC3 (LC3 II) appeared.
DNA damage and necrosis
The DNA fragmentation into oligonucleosomal fragments is a widely recognized hallmark of apoptotic cell death, as induced by HMA (5-N, N-hexamethylene-amiloride) (used as a positive control). The "DNA ladder" pattern was clearly seen in samples treated with Dexa and Dexa-Ph, faintly with TA treatment and not at all in Hydro treated cells (Fig 2C) .
Moreover, as some smear degradation is also seen we investigated if necrosis was involved.
This was done by measuring the release of LDH in the culture medium. A total lysis of the cells induced by 1% Triton-X100 was used as a positive control. Amongst the GCs tested at their respective LC 50 concentrations, only Dexa (255 µM) induced a significant increase of LDH release (31.17%; **P≤0.01) as compared to the positive control (Fig 2D) .
Caspase-dependent apoptosis in GCs toxicity
Caspase-3 activation was analyzed by immunocytochemistry ( Fig 3A) and western blot ( Fig   3B) . Amongst the GCs tested at their respective LC 50 concentrations, only Dexa and Dexa-Ph induced activation of caspase 3 as observed on immunocytochemistry (Fig 3A) . This was confirmed by western blot (Fig 3B) . Only Dexa and Dexa-Ph induced the cleavage of procaspase 3. Moreover, PARP-1, one of the main targets of activated Caspase-3 was cleaved in cells treated with Dexa and Dexa-Ph but not in cells treated with other CGs (Fig 3B) . In all these experiments the treatment of cells with etoposide, an inhibitor of toposiomerase II, knowing to induce caspase dependent cell death was used as a positive control. The involvement of caspases in cell death was evaluated using the pancaspase inhibitor ZVAD-FMK. Results are seen on Fig 3C. The inhibitor successfully inhibits cell death in etoposide but not in GCs treated cells, suggesting that this pathway is not the main effector in GCs cells demise.
Caspase-independent apoptosis in GCs toxicity
Due to the lack of caspase activation in TA and Hydro, as well as the lack of protection with pancaspase inhibitor, we analyzed caspase independent pathways, namely Leukocyte Elastase
Inhibitor (LEI/L-DNase II) and Apoptosis Inducing Factor (AIF).
LEI (Leukocyte Elastase Inhibitor) is a cytoplasmic molecule owning an anti-protease activity. After induction of apoptosis it is cleaved and transformed into L-DNase II, a
molecule that has an endonuclease activity and that is translocated to the nucleus (Padron-
The activation of L-DNase II was estimated by immunostaining and Western blot. L-DNase II activation and nuclear translocation were observed with all GCs (Fig 4A) . In order to verify the nuclear translocation of this protein we fractionated cytoplasms from nuclei, and performed a western blot on both fractions (Fig 4B) . We observed the presence of native LEI (42 KDa) in the cytoplasmic fractions while the nuclear fractions contained, in addition, one band of 35kDa corresponding to the active L-DNase II (Belmokhtar, et al. 2000) .Taken together these results indicate that GCs activate the LEI/L-DNase II pathway. HMA treated cells were used as positive control of L-DNase II activation.
Concerning AIF, (Fig 5) HMEC cells treated with the GCs presented a cytoplasmic dotted
labeling which was compatible with its classical mitochondrial localization.
This localization did not seem modified with the GCs (Fig 5A) . Observe that staurosporine treated cells used as positive control of AIF activation showed a diffuse cytoplasmic labeling and a nuclear peripheral labeling. As previously done, we verified this result by western blot (Fig 5B) after nuclear-cytoplasmic fractionation. The activated, cleaved form of AIF is only seen in staurosporine treated cells. These results indicate that the AIF is not activated by GCs in HMEC cells.
Effect of glucocorticoids on BREC
To verify if the cellular phenomena induced by the GCs on the HMEC were reproducible on retinal endothelial cells, we analyzed the activation of the cell death pathways previously studied.
For this purpose, BREC were treated for 24 h with LC 50, ,then the activation of Caspase-3, LEI/L-DNase II and AIF were estimated by immunostaining with the corresponding antibody.
The activation of Caspase-3 was observed on BREC treated with Dexa and Dexa-Ph, as already indicated for HMEC. Hydro and TA did not induce the caspase dependent cell death (Fig 6C) . In same way, the activation of the LEI and nuclear translocation of L-DNase II were observed with all GCs on BREC (As showed in higher magnifications) (Fig 6A) .The analysis of the immunocytochemistry of AIF on BREC showed a cytoplasmic dotted labeling indicating the mitochondrial localization of AIF with all GCs treatment, while cells treated with the staurosporine (positive control) revealed a diffuse labeling in the cytoplasm and a nuclear translocation (Fig 6B) .
Impact of GCs on the retinal microvasculature
The in vitro experiments described above showed the toxic effects of GCs on HMEC and BREC. In order to be closer to physiological conditions, where the endothelial cells are organized as microvascular networks, rat retina explants were treated with GCs for 24 h at the (Denniston, et al. 2011) . Moreover, in inflammatory conditions, as shown in experimental model of uveitis, cortisol levels increase in the ocular media (Bousquet, et al. 2012) . This permanent exposure to high cortisol levels associated with the low proliferating capacity of retinal endothelial cells may explain their higher resistance to GCs-induced cell death (Joussen, et al. 2007 ).
Although the tested drugs belong to the same pharmacological family, they show different cellular toxicity. Their differential effects could be related to their relative affinity for gluco or mineralocorticoid receptors. Indeed, GCs can exert beneficial or deleterious effects on vascular permeability through junction adhesion and cytoskeleton remodeling (Chen, et al. 2002) . However, the concentration of GCs used here is largely over the binding constant for these receptors (in the µM range) suggesting that the toxic effects are receptor independent.
Concerning endothelial cell toxicity, our results show that the more hydrophilic GCs, namely, Dexamethasone phosphate (Dexa-Ph) is the less toxic than the more lipophilic, Hydro, Dexa, and TA. This difference may be explained, by hydrophilic GCs transferring less easily through the intact membranes, resulting in lower bioavailability in cells and thus less toxic. It is worth noting that the toxicity measured here is not related to the anti-inflammatory activity of these compounds. Compared to Hydro, TA has 5 to10 fold greater anti-inflammatory activity, while
Dexa has 20 to 40 fold greater activity. However, their LC 50 are quite similar (255 µM for Dexa, 230 µM for TA) (Cohen and Jacquot 1981, Le Jeunne 2012) .
TA is the most widely administered intraocular GC and is usually given in a formulation not specifically adapted to ophthalmological use, as it was originally designed for intramuscular and intra-articular administration. Studies on the toxicity of TA and/or its excipient (benzyliquealcohol), the crystalline or soluble formulations, led conflicting rather than conclusive results (Torriglia, et al. 2010 , Valamanesh, et al. 2007 . Indeed, toxicity of TA and its excipient was not found in certain studies (McCuen BW 2nd 1981 , Narayanan, et al. 2006 while other works clearly established the toxicity of TA and/or the excipient in the eye, resulting in a disorganization of the retina layers, a loss of the choroid network density and a vasoconstriction of the retina blood vessels (Morrison, et al. 2006 , Torriglia, et al. 2010 , Valamanesh, et al. 2009 ).
TA showed concentration and time dependent cytotoxicity on retinal pigment epithelium cells, glial cells and endothelial cells of the retina. This toxicity triggered a reduction in mitochondrial activity, and an activation of caspase-independent cell death mechanism (paraptosis in EPR cells, LEI-L-DNase II and AIF in retinal endothelial cells (Narayanan, et al. 2006) , (Valamanesh, et al. 2007 , Yeung, et al. 2003 ). This may explain the results obtained by some authors that showed no caspase activation after 24 h of treatment with TA on primary human retinal microvascular and flat mounted rat retinas (Hartnett, et al. 2006) .
Hence, the assessment of cell death pathways is an essential step in estimating the safety or the toxicity of health products. We show here that different cell death mechanisms other that classical caspase dependent apoptosis are responsible for cell death induced by GCs and that the same mechanisms seen in cell culture were also seen ex-vivo (microvessels of retina).
Moreover, the use of the pancaspase inhibitor, ZVAD on HMEC show a lack of protective activity regarding all the GCs suggesting that caspases are not the main effectors in this cell death.
In this study the toxicity of several GCs was estimated and compared for the first time, on microvascular endothelial cells of different tissue origins. This toxicity was previously disregarded because the tests used were not suitable for evaluating caspase-independent cell death. Strikingly, the concentrations used in our experiments, that proved to be cytotoxic, were lower than those used clinically. For instance, 4 mg of TA are injected in the human vitreous to treat macular edema. This produces a concentration of 1mg/ml (approximately 2.3 mM) of TA in the vitreous (lasting up to 1 month) due to the slow clearance of drugs in this compartment. The vitreous humor levels measured by several authors after triamcinolone acetonide intravitreous injection, are higher than the LC 50 found in both HMEC and BREC (around 4 mM as compared to 230 and 460 µM for HMEC and BREC respectively) (Oliveira, et al. 2012) . 
